These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34305780)

  • 21. The Utility of the Combined Use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Yonago Acta Med; 2018 Jun; 61(2):117-127. PubMed ID: 29946218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT.
    Davidsson A; Georgiopoulos C; Dizdar N; Granerus G; Zachrisson H
    Ann Nucl Med; 2014 Nov; 28(9):851-9. PubMed ID: 24997753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease.
    Sasaki S
    Alzheimers Dement; 2018 Dec; 14(12):1615-1622. PubMed ID: 30222946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More Sensitive Identification for Bradykinesia Compared to Tremors in Parkinson's Disease Based on Parkinson's KinetiGraph (PKG).
    Chen L; Cai G; Weng H; Yu J; Yang Y; Huang X; Chen X; Ye Q
    Front Aging Neurosci; 2020; 12():594701. PubMed ID: 33240078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
    Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
    Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes.
    Hossein-Tehrani MR; Ghaedian T; Hooshmandi E; Kalhor L; Foroughi AA; Ostovan VR
    J Neuroimaging; 2020 Sep; 30(5):683-689. PubMed ID: 32557946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson's disease: 5 years and beyond.
    Tsuboi T; Lemos Melo Lobo Jofili Lopes J; Moore K; Patel B; Legacy J; Ratajska AM; Bowers D; Eisinger RS; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Neurosurg; 2021 Aug; 135(2):601-610. PubMed ID: 33035998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of gait parameters between drug-naïve patients diagnosed with multiple system atrophy with predominant parkinsonism and Parkinson's disease.
    Na BS; Ha J; Park JH; Ahn JH; Kim M; Kim JS; Kim HT; Cho JW; Youn J
    Parkinsonism Relat Disord; 2019 Mar; 60():87-91. PubMed ID: 30266299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using
    Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B
    Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH; Chung SJ; Kim SR; Lee MC
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of the combined use of
    Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
    Acta Radiol; 2019 Feb; 60(2):230-238. PubMed ID: 29804474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Tashiro K; Kikuchi S; Sasaki H
    J Neurol Sci; 2006 Feb; 241(1-2):67-72. PubMed ID: 16352310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort.
    Lachenmayer ML; Bettschen C; Bernasconi C; Petermann K; Debove I; Muellner J; Michelis JP; Burgunder JM; Krauss JK; Oertel MF; Pollo C; Kaelin-Lang A; Schüpbach M
    Parkinsonism Relat Disord; 2019 Jul; 64():118-123. PubMed ID: 30935828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-Related Parkinsonian Signs in Microdeletion 22q11.2.
    Boot E; Mentzel TQ; Palmer LD; van Harten PN; Marras C; Lang AE; Bassett AS
    Mov Disord; 2020 Jul; 35(7):1239-1245. PubMed ID: 32386091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.